MSC 2032964A
CAS No. 1124381-43-6
MSC 2032964A( MSC-2032964A | MSC2032964A | MSC 2032964A )
Catalog No. M27999 CAS No. 1124381-43-6
MSC 2032964A is a potent selective ASK1 inhibitor (IC50 = 93 nM) that is oral bioavailable and brain permeable. It inhibited neuroinflammation in mouse EAE models and blocked LPS-induced phosphorylation of ASK1 and p38 in cultured mouse astrocytes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 240 | Get Quote |
|
| 10MG | 381 | Get Quote |
|
| 25MG | 620 | Get Quote |
|
| 50MG | 883 | Get Quote |
|
| 100MG | 1215 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMSC 2032964A
-
NoteResearch use only, not for human use.
-
Brief DescriptionMSC 2032964A is a potent selective ASK1 inhibitor (IC50 = 93 nM) that is oral bioavailable and brain permeable. It inhibited neuroinflammation in mouse EAE models and blocked LPS-induced phosphorylation of ASK1 and p38 in cultured mouse astrocytes.
-
DescriptionMSC 2032964A is a potent selective ASK1 inhibitor (IC50 = 93 nM) that is oral bioavailable and brain permeable. It inhibited neuroinflammation in mouse EAE models and blocked LPS-induced phosphorylation of ASK1 and p38 in cultured mouse astrocytes.
-
In Vitro——
-
In Vivo——
-
SynonymsMSC-2032964A | MSC2032964A | MSC 2032964A
-
PathwayOthers
-
TargetOther Targets
-
RecptorCalcium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1124381-43-6
-
Formula Weight362.316
-
Molecular FormulaC16H13F3N6O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFC(F)(F)c1cc(NC2CC2)n2nc(NC(=O)c3cccnc3)nc2c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Samy MEROUEH, et al. Preparation of pyrazolyl acylpyrazolines for the treatment of pain. WO2020061303A1
molnova catalog
related products
-
2,3-dihydro-1H-inden...
2,3-dihydro-1H-indene-5-sulfonamide is Carbonic anhydrase 12 (human) inhibitor.
-
Mogroside III-A2
Mogroside III-A2 exhibits inhibitory effects with IC50 values of 346-400 mol ratio/32 pmol TPA. and shows weak inhibitory effects on activation of (+/-)-(E)-methyl-2-[(E)-hydroxyimino]-5-nitro-6-methoxy-3-hexemide (NOR 1), a nitric oxide (NO) donor.
-
Litifilimab
Litifilimab, a humanized IgG1-κ antibody, targets the C-type lectin domain family 4 member C (CLEC4C) and has potential applications in the study of cutaneous lupus erythematosus (CLE) .
Cart
sales@molnova.com